Abstract
The Covid-19 Pandemic Policy Monitor (COV-PPM) prospectively documents the measures taken to contain SARS-Cov-2 transmission across countries in EU27, EEA and UK. In Germany, measures have also been documented at the federal state and, partially, at the district levels. Non-pharmaceutical interventions (NPIs) implemented since March 2020 have been retrieved and updated weekly from official governments webpages, Ministries of Health, National (Public) Health Institutes or Administrations. NPI categories refer to restrictions, closures or changes in functioning implemented in thirteen domains: public events (gatherings in indoor or outdoor spaces); public institutions (kindergartens, schools, universities); public transport (trains, buses, trams, metro); citizens movement/mobility (e.g. pedestrians, cars, ships); border closures (air, land or sea, all incoming travels, from high-risk regions, only non-nationals); measures to improve the healthcare system (e.g. human resources or technical reinforcement, redistribution, material or infrastructural); measures for risk/vulnerable groups (e.g. elderly, chronically ill, pregnant); economic measures (e.g. lay-off rules establishment, actions to avoid job-loss, tax relaxation); testing policies (e.g. testing criteria changes); nose and mouth protection rules, vaccination and others/miscellaneous measures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We acknowledge financial support by the Rectorate of Bielefeld University, and the Federal Ministry of Health Germany (ZMV I 1 - 25 20 COR 410).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study is based on publicly available data, no ethical clearance was required
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The dataset along with codes (prepared with R) to generate analytical variables can be accessed via Harvard Dataverse repository (https://doi.org/10.7910/DVN/ANTOH7). The data and code is for public, scientific, non-commercial use and can be retrieved upon reasonable request by submitting a proposal to kayvan.bozorgmehr@uni-bielefeld.de.
